BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 12974537)

  • 21. Aerosol therapy.
    Hess D
    Respir Care Clin N Am; 1995 Dec; 1(2):235-63. PubMed ID: 9390861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma.
    Kunkel G; Chuchalin AG
    Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S15-7. PubMed ID: 11385811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Could interchangeable use of dry powder inhalers affect patients?
    Price D; Summers M; Zanen P
    Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
    Munzel U; Marschall K; Fyrnys B; Wedel M
    Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of asthma using aerosols].
    Negro JM; Sarrió E; Millares JC; Hernández J; Garcia Sellés FJ; Pagán JA; López Sánchez JD
    Allergol Immunopathol (Madr); 1996; 24(4):139-45. PubMed ID: 9012269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dry powder inhaler formulation.
    Telko MJ; Hickey AJ
    Respir Care; 2005 Sep; 50(9):1209-27. PubMed ID: 16122404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do healthcare professionals think that dry powder inhalers can be used interchangeably?
    Price D
    Int J Clin Pract Suppl; 2005 Dec; (149):26-9. PubMed ID: 16280000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to achieve good compliance with inhaled asthma therapy.
    Crompton GK
    Respir Med; 2004 Oct; 98 Suppl B():S35-40. PubMed ID: 15481287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methods for administration of anti-asthma inhalation drugs].
    Fjellbirkeland L; Gulsvik A
    Tidsskr Nor Laegeforen; 1990 Jun; 110(16):2092-5. PubMed ID: 2368076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
    Amirav I; Newhouse MT; Mansour Y
    Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieving asthma control.
    Barnes PJ
    Curr Med Res Opin; 2005; 21 Suppl 4():S5-9. PubMed ID: 16138939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dry powder inhalers for pulmonary drug delivery.
    Frijlink HW; De Boer AH
    Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Part II: Inhaler technique and adherence to therapy.
    Blaiss MS
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S13-20. PubMed ID: 17925064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.
    Knoch M; Keller M
    Expert Opin Drug Deliv; 2005 Mar; 2(2):377-90. PubMed ID: 16296761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.